个人中心 - 老虎社区

sundar

IP属地：未知

帖子 · 25帖子 · 25
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- sundarsundar
  ·2021-09-01
  $SouthernAlliance(QNS.SI)$IS GROWING
  38 评论
  点赞
  分享
  举报
- sundarsundar
  ·2021-08-13
  Ok
  Americans With Weak Immune Systems Will Get 3 Covid Shots
  Americans with weakened immune systems will be allowed to get three shots of Covid-19 vaccine after
  Americans With Weak Immune Systems Will Get 3 Covid Shots
  25 1
  3
  分享
  举报
- sundarsundar
  ·2021-08-11
  $Lion-OSPL China L S$(YYY.SI)$
  10 评论
  4
  分享
  举报
- sundarsundar
  ·2021-08-04
  It is growing and growing
  14 评论
  点赞
  分享
  举报
- sundarsundar
  ·2021-08-02
  Really
  非常抱歉，此主贴已删除
  39 1
  3
  分享
  举报
- sundarsundar
  ·2021-08-02
  $Lion-OSPL China L S$(YYY.SI)$Money growing liao
  11 评论
  3
  分享
  举报
- sundarsundar
  ·2021-08-02
  Growing
  86 评论
  点赞
  分享
  举报
- sundarsundar
  ·2021-08-02
  Another game changer
  2 评论
  点赞
  分享
  举报
- sundarsundar
  ·2021-08-02
  $Lion-OSPL China L S$(YYY.SI)$The new big player faster buy it is growjng
  116 评论
  点赞
  分享
  举报
- sundarsundar
  ·2021-07-29
  Great great great
  Qualcomm optimistic on 5G, connected device sales as supply bottlenecks ease
  (Reuters) -Qualcomm Inc on Wednesday predicted a rise in sales of chips for 5G phones, including App
  Qualcomm optimistic on 5G, connected device sales as supply bottlenecks ease
  52 1
  3
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3582718999759988","uuid":"3582718999759988","gmtCreate":1619624975993,"gmtModify":1620562807989,"name":"sundar","pinyin":"sundar","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":29,"tweetSize":25,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":816968066,"gmtCreate":1630461082555,"gmtModify":1631886376989,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QNS.SI\">$SouthernAlliance(QNS.SI)$</a>IS GROWING","listText":"<a href=\"https://laohu8.com/S/QNS.SI\">$SouthernAlliance(QNS.SI)$</a>IS GROWING","text":"$SouthernAlliance(QNS.SI)$IS GROWING","images":[{"img":"https://static.tigerbbs.com/585774ec6ce5d0d8882f0709422c04e8","width":"1080","height":"2172"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/816968066","isVote":1,"tweetType":1,"viewCount":38,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":894770978,"gmtCreate":1628860682394,"gmtModify":1631890718749,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"&nbsp;Ok","listText":"&nbsp;Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894770978","repostId":"1121308321","repostType":4,"repost":{"id":"1121308321","kind":"news","pubTimestamp":1628859436,"share":"https://ttm.financial/m/news/1121308321?lang=&edition=full","pubTime":"2021-08-13 20:57","market":"us","language":"en","title":"Americans With Weak Immune Systems Will Get 3 Covid Shots","url":"https://stock-news.laohu8.com/highlight/detail?id=1121308321","media":"Bloomberg","summary":"Americans with weakened immune systems will be allowed to get three shots of Covid-19 vaccine after ","content":"<p>Americans with weakened immune systems will be allowed to get three shots of Covid-19 vaccine after U.S. regulators authorized giving an extra dose to the most vulnerable people.</p>\n<p>The U.S. Food and Drug Administration’s action expands the use of vaccines fromModerna Inc.and the partnership ofPfizer Inc.andBioNTech SEfor organ transplant recipients and patients with other conditions like cancer that hobble the body’s natural infection-fighting response. The decision doesn’t apply to other fully vaccinated individuals, the agency said in astatement.</p>\n<p>The U.S. is currently facing a surge of infections spawned by the highly infectious delta variant, with more than 117,000 new cases diagnosed yesterday. The FDA’s move was designed to protect those people most likely to be harmed or die from an infection, even after a standard course of shots.</p>\n<p>“The country has entered yet another wave of the Covid-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease,” said Acting Commissioner Janet Woodcock. “After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna vaccines.”</p>\n<p>Vaccine Access</p>\n<p>The decision could further exacerbate the vaccine inequality that exists across the world. The U.S. is joining countries including Israel, Germany and France in offering boosters to vulnerable groups, while nations including Russia and the United Arab Emirates are giving them even more broadly. The European Union’s drugs regulatorsaidFriday that it’s coordinating with vaccine makers and reviewing data on third shots.</p>\n<p>Meanwhile, dozens of countries have such limited access to the vaccines that they have immunized fewer than 10% of their populations.</p>\n<p>The FDA’s decision was supported by a study published in the New England Journal of Medicine on Wednesday, showing that a third dose of Moderna’s vaccine significantly raised levels of Covid-fighting antibodies in 55% of transplant patients. Among those who got a placebo rather than the extra shot, just 18% generated the desired antibody levels, thestudyfound.</p>\n<p>“Ifeelvery relieved that they are doing this, because it will save lives,” said Janet Handal, a kidney transplant recipient. “I wish that they had done it sooner.”</p>\n<p>While the U.S.-authorized Covid-19 vaccines are highly effective at preventing severe disease, hospitalization and death in most people, booster shots are especially important for transplant patients and others with weak immune systems, who often don’t get adequate responses to their first vaccine course. Immune compromised people compose about 3% of adults, Rochelle Walensky, director of the Centers for Disease Control and Prevention, said on a press call.</p>\n<p>Many patients had sought out extra doses on their own as findings emerged on their responses to vaccines. Dorry Segev, a professor of surgery and epidemiology at Johns Hopkins University, said his research team has observed more than 200 transplant recipients who have gotten third shots, and he suspects many more immunocompromised patients have done so as well.</p>\n<p>Advisers for the CDC raised concerns at a meeting last month about patients getting additional doses in an unsupervised manner and the inequities that could arise.</p>\n<p>“The people who’ve gotten it now are the people who navigate the health care system well, who are willing to go to great lengths,” Segev said. FDA approval “would then expand access of these boosters in a more equitable way to people who might not be as good as navigating the health care system and might have been too shy or too worried about pursuing something.”</p>\n<p>The FDA’s action allows for a third shot at least 28 days after the initial two-dose regimen in organ transplant recipients and patients with conditions “considered to have an equivalent level of immunocompromise.” Immune compromising conditions include blood cancers, HIV, multiple sclerosis and many others. In some cases, patients’ conditions weaken the immune system; in others, it’s their medications. Among the various conditions, the degree of immune suppression may differ.</p>\n<p>Not all patients may develop an antibody response after the third dose, as research so far has shown. Until there’s more information about how much protection patients have after a third dose and until the delta wave subsides, patients should still continue to mask and social distance, Segev said.</p>\n<p>Only those with weakened immune systems will be offered boosters, White House chief medical adviser Anthony Fauci said on NBC’s ”Today” show. For other vaccinated groups, such as the elderly, data is being collected to determine if or when their protection goes “below a critical level.”</p>\n<p>“Right now at this moment, other than the immune-compromised, we’re not going to be giving boosters to people, but we will be following them very carefully, and if they do need it, we’ll be ready to give it to them,” he said.</p>\n<p>About 60% of eligible Americans, age 12 and older, are fully vaccinated, according to the CDC. And while the pace of immunization is rising after falling sharply from a high point in mid-April, the Biden administration is urging people to get shots as infections surge in the U.S., fueled by the delta variant.</p>\n<p>An advisory committee to the CDC is also set to discuss booster doses of Covid–19 vaccine for immunocompromised patients on Friday.</p>\n<p>Handal and other transplant recipients formed Transplant Recipients and Immunocompromised Patient Advocacy Group during the pandemic that has urged the FDA to streamline approval of additional doses for those with weakened immune systems.</p>\n<p>“People that are immunocompromised are continuing to live with the fear that everyonefeltin the early days of Covid,” Handal said in an interview. They’re carrying on with their lives as the world opens up, but “it’s just an undercurrent of fear, and it’s exhausting to live with.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Americans With Weak Immune Systems Will Get 3 Covid Shots</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmericans With Weak Immune Systems Will Get 3 Covid Shots\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 20:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-13/u-s-clears-third-covid-shot-for-immunocompromised-patients><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Americans with weakened immune systems will be allowed to get three shots of Covid-19 vaccine after U.S. regulators authorized giving an extra dose to the most vulnerable people.\nThe U.S. Food and ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-13/u-s-clears-third-covid-shot-for-immunocompromised-patients\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-08-13/u-s-clears-third-covid-shot-for-immunocompromised-patients","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121308321","content_text":"Americans with weakened immune systems will be allowed to get three shots of Covid-19 vaccine after U.S. regulators authorized giving an extra dose to the most vulnerable people.\nThe U.S. Food and Drug Administration’s action expands the use of vaccines fromModerna Inc.and the partnership ofPfizer Inc.andBioNTech SEfor organ transplant recipients and patients with other conditions like cancer that hobble the body’s natural infection-fighting response. The decision doesn’t apply to other fully vaccinated individuals, the agency said in astatement.\nThe U.S. is currently facing a surge of infections spawned by the highly infectious delta variant, with more than 117,000 new cases diagnosed yesterday. The FDA’s move was designed to protect those people most likely to be harmed or die from an infection, even after a standard course of shots.\n“The country has entered yet another wave of the Covid-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease,” said Acting Commissioner Janet Woodcock. “After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna vaccines.”\nVaccine Access\nThe decision could further exacerbate the vaccine inequality that exists across the world. The U.S. is joining countries including Israel, Germany and France in offering boosters to vulnerable groups, while nations including Russia and the United Arab Emirates are giving them even more broadly. The European Union’s drugs regulatorsaidFriday that it’s coordinating with vaccine makers and reviewing data on third shots.\nMeanwhile, dozens of countries have such limited access to the vaccines that they have immunized fewer than 10% of their populations.\nThe FDA’s decision was supported by a study published in the New England Journal of Medicine on Wednesday, showing that a third dose of Moderna’s vaccine significantly raised levels of Covid-fighting antibodies in 55% of transplant patients. Among those who got a placebo rather than the extra shot, just 18% generated the desired antibody levels, thestudyfound.\n“Ifeelvery relieved that they are doing this, because it will save lives,” said Janet Handal, a kidney transplant recipient. “I wish that they had done it sooner.”\nWhile the U.S.-authorized Covid-19 vaccines are highly effective at preventing severe disease, hospitalization and death in most people, booster shots are especially important for transplant patients and others with weak immune systems, who often don’t get adequate responses to their first vaccine course. Immune compromised people compose about 3% of adults, Rochelle Walensky, director of the Centers for Disease Control and Prevention, said on a press call.\nMany patients had sought out extra doses on their own as findings emerged on their responses to vaccines. Dorry Segev, a professor of surgery and epidemiology at Johns Hopkins University, said his research team has observed more than 200 transplant recipients who have gotten third shots, and he suspects many more immunocompromised patients have done so as well.\nAdvisers for the CDC raised concerns at a meeting last month about patients getting additional doses in an unsupervised manner and the inequities that could arise.\n“The people who’ve gotten it now are the people who navigate the health care system well, who are willing to go to great lengths,” Segev said. FDA approval “would then expand access of these boosters in a more equitable way to people who might not be as good as navigating the health care system and might have been too shy or too worried about pursuing something.”\nThe FDA’s action allows for a third shot at least 28 days after the initial two-dose regimen in organ transplant recipients and patients with conditions “considered to have an equivalent level of immunocompromise.” Immune compromising conditions include blood cancers, HIV, multiple sclerosis and many others. In some cases, patients’ conditions weaken the immune system; in others, it’s their medications. Among the various conditions, the degree of immune suppression may differ.\nNot all patients may develop an antibody response after the third dose, as research so far has shown. Until there’s more information about how much protection patients have after a third dose and until the delta wave subsides, patients should still continue to mask and social distance, Segev said.\nOnly those with weakened immune systems will be offered boosters, White House chief medical adviser Anthony Fauci said on NBC’s ”Today” show. For other vaccinated groups, such as the elderly, data is being collected to determine if or when their protection goes “below a critical level.”\n“Right now at this moment, other than the immune-compromised, we’re not going to be giving boosters to people, but we will be following them very carefully, and if they do need it, we’ll be ready to give it to them,” he said.\nAbout 60% of eligible Americans, age 12 and older, are fully vaccinated, according to the CDC. And while the pace of immunization is rising after falling sharply from a high point in mid-April, the Biden administration is urging people to get shots as infections surge in the U.S., fueled by the delta variant.\nAn advisory committee to the CDC is also set to discuss booster doses of Covid–19 vaccine for immunocompromised patients on Friday.\nHandal and other transplant recipients formed Transplant Recipients and Immunocompromised Patient Advocacy Group during the pandemic that has urged the FDA to streamline approval of additional doses for those with weakened immune systems.\n“People that are immunocompromised are continuing to live with the fear that everyonefeltin the early days of Covid,” Handal said in an interview. They’re carrying on with their lives as the world opens up, but “it’s just an undercurrent of fear, and it’s exhausting to live with.”","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":25,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892631427,"gmtCreate":1628653273469,"gmtModify":1631888768357,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/YYY.SI\">$Lion-OSPL China L S$(YYY.SI)$</a>","listText":"<a href=\"https://laohu8.com/S/YYY.SI\">$Lion-OSPL China L S$(YYY.SI)$</a>","text":"$Lion-OSPL China L S$(YYY.SI)$","images":[{"img":"https://static.tigerbbs.com/1a450118ccd248252f390c6750da2011","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892631427","isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":807587774,"gmtCreate":1628043907998,"gmtModify":1631890718754,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"It is growing and growing","listText":"It is growing and growing","text":"It is growing and growing","images":[{"img":"https://static.tigerbbs.com/a9ead70dfeab9a0386d1fa0000a7f38c","width":"1080","height":"2192"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807587774","isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":804940883,"gmtCreate":1627917883842,"gmtModify":1631890718758,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"Really","listText":"Really","text":"Really","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/804940883","repostId":"1107596279","repostType":4,"isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805685753,"gmtCreate":1627876399372,"gmtModify":1631888768483,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/YYY.SI\">$Lion-OSPL China L S$(YYY.SI)$</a>Money growing liao","listText":"<a href=\"https://laohu8.com/S/YYY.SI\">$Lion-OSPL China L S$(YYY.SI)$</a>Money growing liao","text":"$Lion-OSPL China L S$(YYY.SI)$Money growing liao","images":[{"img":"https://static.tigerbbs.com/6411195bf62da8a89c09b6ff297fda74","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805685753","isVote":1,"tweetType":1,"viewCount":11,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805875810,"gmtCreate":1627872895730,"gmtModify":1631890718760,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"Growing","listText":"Growing","text":"Growing","images":[{"img":"https://static.tigerbbs.com/e9b2800a4af26f8f5b54de7263922529","width":"1080","height":"2192"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805875810","isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805844669,"gmtCreate":1627872336451,"gmtModify":1631890718763,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"Another game changer","listText":"Another game changer","text":"Another game changer","images":[{"img":"https://static.tigerbbs.com/96321367d180f3edaa954d781fa55e07","width":"1080","height":"2192"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805844669","isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805841399,"gmtCreate":1627871962911,"gmtModify":1631888768491,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/YYY.SI\">$Lion-OSPL China L S$(YYY.SI)$</a>The new big player faster buy it is growjng","listText":"<a href=\"https://laohu8.com/S/YYY.SI\">$Lion-OSPL China L S$(YYY.SI)$</a>The new big player faster buy it is growjng","text":"$Lion-OSPL China L S$(YYY.SI)$The new big player faster buy it is growjng","images":[{"img":"https://static.tigerbbs.com/98c90bd0eced43f26f5510308c6f2888","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805841399","isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":801438246,"gmtCreate":1627526982885,"gmtModify":1631890718771,"author":{"id":"3582718999759988","authorId":"3582718999759988","name":"sundar","avatar":"https://static.tigerbbs.com/2fc80fc71347712ae1eb11c6b6f83982","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582718999759988","authorIdStr":"3582718999759988"},"themes":[],"htmlText":"Great great great","listText":"Great great great","text":"Great great great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/801438246","repostId":"1191373397","repostType":4,"repost":{"id":"1191373397","kind":"news","pubTimestamp":1627514021,"share":"https://ttm.financial/m/news/1191373397?lang=&edition=full","pubTime":"2021-07-29 07:13","market":"us","language":"en","title":"Qualcomm optimistic on 5G, connected device sales as supply bottlenecks ease","url":"https://stock-news.laohu8.com/highlight/detail?id=1191373397","media":"Reuters","summary":"(Reuters) -Qualcomm Inc on Wednesday predicted a rise in sales of chips for 5G phones, including App","content":"<p>(Reuters) -Qualcomm Inc on Wednesday predicted a rise in sales of chips for 5G phones, including Apple Inc’s iPhone, as the company said it had mitigated supply shortfalls that have contributed to a global chip shortage.</p>\n<p>Qualcomm total revenues rose 63% to nearly $8 billion, boosted by soaring sales of chips for connected devices that hit $1.4 billion.</p>\n<p>The San Diego, California-based company is the biggest supplier of mobile phone chips in the world and the leader in 5G technology, supplying modem chips that help iPhones connect to wireless data networks and the modems and central processors for much of the Android market.</p>\n<p>Shares were up 2.5% to $146 in after-market trading following the results, which could alleviate some concerns among investors about the impact of the shortage on the smart phone market, including the iPhone.</p>\n<p>Qualcomm Chief Executive Officer Cristiano Amon told investors during a conference call that the company’s efforts to secure its chips from multiple manufacturing partners were making progress bolstering supplies, with the first shipments of significant volume in the fiscal third quarter and more to come in the coming months.</p>\n<p>“We’re still on track to materially improve supply by the end of the calendar year,” Amon said.</p>\n<p>The company is also benefiting from the exit from the global smartphone market of China’s Huawei Technologies Co Ltd. Huawei’s flagship models did not use Qualcomm chips but its rivals, who are now snapping up market share, mostly do.</p>\n<p>Qualcomm has boosted sales of other chips, such as radio-frequency chips that augment its 5G phone chips and whose sales have doubled in the past year. Sales are also growing for a variety of chips for cars and for “internet of things,” or IoT, applications.</p>\n<p>Qualcomm said on Wednesday it expects sales of those chips to hit $10 billion this fiscal year, up from $6 billion the previous year. The company also said it expects adjusted profits of $8.24 per share for its fiscal 2021, nearly double the year before.</p>\n<p>Qualcomm’s chip revenue forecast for the current fiscal fourth quarter had a midpoint of $7.25 billion, compared with analyst estimates of $6.83 billion, according to Refinitiv data.</p>\n<p>CHIP SHORTAGE</p>\n<p>Amon said even as its own bottlenecks ease as it brings on more manufacturing partners, some of Qualcomm’s customers cannot find the supporting chips from other vendors that they need to make full devices.</p>\n<p>“We continue to see strong demand in every single business outpacing supply,” he said on the call.</p>\n<p>Apple on Tuesday predicted the chip shortage would start to hit its iPhone in the fourth quarter.</p>\n<p>On Wednesday, Qualcomm said that global sales of 5G handsets for 2021 was likely to come in at the higher end of its forecast of 450 to 550 million handsets. That means that phone makers are likely directing any chips that are in short supply toward production of their more profitable 5G devices. Apple shares rose 0.14% in after-hours trading after Qualcomm’s results.</p>\n<p>“While there remain some parts tightness in some periphery chips in the smartphone sector, we don’t think its material enough to cause any meaningful downside, as the industry will prioritize the supply for 5G instead of 4G,” said Kinngai Chan, an analyst at Summit Insights Group.</p>\n<p>Qualcomm forecast overall sales and adjusted profits with midpoints of $8.8 billion and $2.25 per share, above estimates of $8.50 billion and $2.04 per share, according to Refinitiv data.</p>\n<p>The company predicted revenue with a midpoint of $1.55 billion from its patent licensing business, compared with analyst expectations of $1.56 billion, according to Refinitiv data.</p>\n<p>For the fiscal third quarter ended June 27, Qualcomm said overall adjusted revenues and adjusted profits were $8 billion and $1.92 per share, higher than estimates of $7.58 billion and $1.68 per share, according to Refinitiv data.</p>\n<p>Mobile handset chips remain Qualcomm’s biggest seller, increasing 57% to hit $3.86 billion in the quarter.</p>\n<p>“Qualcomm has done a phenomenal job in driving the 5G ecosystem. For sure it’s moving a lot faster than 4G,” said Paolo Pescatore, an analyst at PP Foresight.</p>\n<p>Sales of other chips have also been expanding, with radio frequency chips and IoT chips reaching sales of $957 million and $1.4 billion, up 114% and 83% from a year earlier, respectively.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qualcomm optimistic on 5G, connected device sales as supply bottlenecks ease</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQualcomm optimistic on 5G, connected device sales as supply bottlenecks ease\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-29 07:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/qualcomm-results/update-4-qualcomm-optimistic-on-5g-connected-device-sales-as-supply-bottlenecks-ease-idUSL1N2P432P><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -Qualcomm Inc on Wednesday predicted a rise in sales of chips for 5G phones, including Apple Inc’s iPhone, as the company said it had mitigated supply shortfalls that have contributed to a ...</p>\n\n<a href=\"https://www.reuters.com/article/qualcomm-results/update-4-qualcomm-optimistic-on-5g-connected-device-sales-as-supply-bottlenecks-ease-idUSL1N2P432P\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QCOM":"高通"},"source_url":"https://www.reuters.com/article/qualcomm-results/update-4-qualcomm-optimistic-on-5g-connected-device-sales-as-supply-bottlenecks-ease-idUSL1N2P432P","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191373397","content_text":"(Reuters) -Qualcomm Inc on Wednesday predicted a rise in sales of chips for 5G phones, including Apple Inc’s iPhone, as the company said it had mitigated supply shortfalls that have contributed to a global chip shortage.\nQualcomm total revenues rose 63% to nearly $8 billion, boosted by soaring sales of chips for connected devices that hit $1.4 billion.\nThe San Diego, California-based company is the biggest supplier of mobile phone chips in the world and the leader in 5G technology, supplying modem chips that help iPhones connect to wireless data networks and the modems and central processors for much of the Android market.\nShares were up 2.5% to $146 in after-market trading following the results, which could alleviate some concerns among investors about the impact of the shortage on the smart phone market, including the iPhone.\nQualcomm Chief Executive Officer Cristiano Amon told investors during a conference call that the company’s efforts to secure its chips from multiple manufacturing partners were making progress bolstering supplies, with the first shipments of significant volume in the fiscal third quarter and more to come in the coming months.\n“We’re still on track to materially improve supply by the end of the calendar year,” Amon said.\nThe company is also benefiting from the exit from the global smartphone market of China’s Huawei Technologies Co Ltd. Huawei’s flagship models did not use Qualcomm chips but its rivals, who are now snapping up market share, mostly do.\nQualcomm has boosted sales of other chips, such as radio-frequency chips that augment its 5G phone chips and whose sales have doubled in the past year. Sales are also growing for a variety of chips for cars and for “internet of things,” or IoT, applications.\nQualcomm said on Wednesday it expects sales of those chips to hit $10 billion this fiscal year, up from $6 billion the previous year. The company also said it expects adjusted profits of $8.24 per share for its fiscal 2021, nearly double the year before.\nQualcomm’s chip revenue forecast for the current fiscal fourth quarter had a midpoint of $7.25 billion, compared with analyst estimates of $6.83 billion, according to Refinitiv data.\nCHIP SHORTAGE\nAmon said even as its own bottlenecks ease as it brings on more manufacturing partners, some of Qualcomm’s customers cannot find the supporting chips from other vendors that they need to make full devices.\n“We continue to see strong demand in every single business outpacing supply,” he said on the call.\nApple on Tuesday predicted the chip shortage would start to hit its iPhone in the fourth quarter.\nOn Wednesday, Qualcomm said that global sales of 5G handsets for 2021 was likely to come in at the higher end of its forecast of 450 to 550 million handsets. That means that phone makers are likely directing any chips that are in short supply toward production of their more profitable 5G devices. Apple shares rose 0.14% in after-hours trading after Qualcomm’s results.\n“While there remain some parts tightness in some periphery chips in the smartphone sector, we don’t think its material enough to cause any meaningful downside, as the industry will prioritize the supply for 5G instead of 4G,” said Kinngai Chan, an analyst at Summit Insights Group.\nQualcomm forecast overall sales and adjusted profits with midpoints of $8.8 billion and $2.25 per share, above estimates of $8.50 billion and $2.04 per share, according to Refinitiv data.\nThe company predicted revenue with a midpoint of $1.55 billion from its patent licensing business, compared with analyst expectations of $1.56 billion, according to Refinitiv data.\nFor the fiscal third quarter ended June 27, Qualcomm said overall adjusted revenues and adjusted profits were $8 billion and $1.92 per share, higher than estimates of $7.58 billion and $1.68 per share, according to Refinitiv data.\nMobile handset chips remain Qualcomm’s biggest seller, increasing 57% to hit $3.86 billion in the quarter.\n“Qualcomm has done a phenomenal job in driving the 5G ecosystem. For sure it’s moving a lot faster than 4G,” said Paolo Pescatore, an analyst at PP Foresight.\nSales of other chips have also been expanding, with radio frequency chips and IoT chips reaching sales of $957 million and $1.4 billion, up 114% and 83% from a year earlier, respectively.","news_type":1,"symbols_score_info":{"QCOM":0.9}},"isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}